Axon Enterprise, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Axon Enterprise, Inc. reported a 33.5% increase in net sales to $2.8 billion for 2025, but net income significantly decreased to $124.7 million from $377.0 million in the prior year, alongside a material weakness in internal controls.
NASDAQ
Axon Enterprise files an amended 10-K/A to restate prior financial statements due to an error in classifying convertible senior notes and discloses an additional material weakness in internal controls.
NASDAQ
10-K: Axon Enterprise Reports Strong Revenue Growth, Identifies Material Weakness in Internal Controls
Axon Enterprise's 2024 10-K filing reveals a 33.4% increase in revenue alongside the identification of a material weakness in internal controls related to revenue recognition.
NASDAQ
Axon Enterprise's 10-K filing details the company's registered common stock, preferred stock authorization, and various corporate governance and anti-takeover provisions.